If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
A 63-year-old woman with a medical history of hypertension, hypothyroidism, and GERD presented to our clinic with worsening dysphagia to solids. EGD performed by a local gastroenterologist showed a large esophageal mass. CT of the chest with contrast material revealed a high-density, nearly occlusive, esophageal mass, beginning at the thoracic inlet, measuring 3.8 cm × 2.1 cm × 10.4 cm (transverse, anteroposterior, craniocaudal), and demonstrating well-delineated smooth margins without esophageal disruption (Fig. 1).
Figure 1CT with contrast material showing esophageal mass at the level of the carina.
EGD was repeated at our facility and revealed a large pedunculated subepithelial mass in the upper third of the esophagus, extending 17 to 30 cm from the incisors (Fig. 2). The mass was partially obstructive, and the endoscope was able to traverse it with minimal resistance. EUS revealed a hypoechoic mucosal mass without submucosal invasion, with a feeding vessel at the stalk (Fig. 3).
Figure 2EGD view showing large pedunculated subepithelial lesion.
In a multidisciplinary meeting, it was decided to attempt endoscopic resection first, because of the lower risk of morbidity and mortality compared with surgical cervical esophagotomy (Video 1, available online at www.VideoGIE.org). The plan was to perform endoloop-assisted endoscopic resection with the endoloop functioning as a tourniquet to prevent postresection bleeding, given that the lesion had a feeding vessel at the stalk. The endoloop (Polyloop; Olympus America, Chelmsford, Mass, USA) is floppy, and it was not possible to place it in a forward view because of the intraluminal bulkiness of the lesion.
The distal third of the esophagus was dilated to allow for retroflexion in the esophagus. In retroflexion, the endoloop was negotiated around the mass, and its sheath was advanced upward toward the stalk to account for distal movement of the sheath upon un-retroflexion. The scope and the endoloop sheath were then un-retroflexed while the endoloop remained around the mass. The endoloop was then successfully placed and tightened at the base of the stalk. The lesion then turned purple, confirming successful tamponading of the feeding vessel.
An extra-large, rounded, stiff 33-mm snare (Captivator; Boston Scientific, Marlborough, Mass, USA) was then negotiated around the mass and tightened about 3 mm above the endoloop with the same technique as the endoloop placement. Blended current was applied for about 15 seconds with the use of Endocut Q mode (ERBE USA, Marietta, Ga, USA) with effect 2, cut duration 1, and cut interval 3. The mass was successfully cut. However, the endoloop did not hold; it fell off after resection of the mass because of the thickness of the stalk. It is also possible that the back, nonvisible portion of the endoloop was entrapped inside the snare, but no cautery marks were seen on the endoloop upon endoscopic inspection. A bleeding vessel was seen at the base of the resection site. The bleeding was successfully controlled by thermal therapy with use of a hemostatic grasper (Coagrasper Hemostatic Forceps; Olympus America). The mass was retrieved in 1 piece by use of the same snare (Fig. 4).
The patient was admitted for 12-hour observation, during which she was completely asymptomatic and was able to tolerate soft food before being discharged home.
Pathologic findings of the removed esophageal mass revealed atypical spindle cells that were positive for BCL-2, vimentin, CD34, and STAT-6. The findings were consistent with solitary fibrous tumor (SFT) with giant cells (Fig. 5). A follow-up EGD performed 2 months later showed a healed scar with no residual lesion (Fig. 6).
Figure 5Microscopic view of spindle tumor cells around gaping vessels (H&E, orig. mag. ×40).
An SFT is a neoplasm of mesenchymal origin that presents with a wide range of biologic behavior. SFTs are commonly known to involve the visceral pleura, but esophageal involvement rarely can occur.
Clinicopathologic models for risk prediction are available; however, the molecular predictors for malignant potential in SFTs are yet to be elucidated.
Overall, SFTs of the esophagus are considered to be benign. The mainstay of treatment is removal with clear margins, followed by histopathologic confirmation of benign behavior.
The preferred treatment method of primary esophageal SFT is yet to be determined, but the majority of cases have been treated surgically. Only 1 recent case report described successful endoscopic submucosal dissection of the tumor.
To our knowledge, this is the first report of the resection of an esophageal giant SFT by endoloop-assisted endoscopic resection. This approach could be considered if there is no submucosal involvement of such lesions.
Disclosure
Dr El Chafic is a consultant for Medtronic. Dr Shah is a consultant for Boston Scientific and Olympus Medical. All other authors disclosed no financial relationships relevant to this publication.
30144-9&id=gr1.jpg){kind=link}
30144-9&id=gr2.jpg){kind=link}
30144-9&id=gr3.jpg){kind=link}
30144-9&id=gr4.jpg){kind=link}
30144-9&id=gr5.jpg){kind=link}
30144-9&id=gr6.jpg){kind=link}